Anavex Life Sciences Corp.
Peter D.O. Donhauser (Director) reports AVXL insider transactions
About this filing
Anavex Life Sciences Corp. (AVXL) filed Form 4 (insider transaction) with the SEC on Nov 6, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Peter D.O. Donhauser · Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | A · grantStock Option (Right to Buy)Footnotes F1 | +50,000 | $0.00 | $0.00 | 50,000 | Direct |
Footnotes
- F1 The option vests in three substantially equal annual installments beginning on March 31, 2027
More AVXL filings
- 4
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 8-K
Filed Nov 3, 2026
- 8-K
Filed Nov 2, 2026
- 8-K
Filed Oct 20, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.